Polysaccharides in oxygen-carrier blood substitutes

Polysaccharides in Medicinal Applications

Volumn , Issue , 2017, Pages 525-544

  Dellacherie, Edith ^a  

^a UNIVERSITÉ DE LORRAINE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

STARCH;

HIGH MOLECULAR WEIGHT; HYDROXYETHYL STARCHES; OXYGEN CARRIER;

OXYGEN;

EID: 85052563629     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1201/9780203742815     Document Type: Chapter

References (106)

1. P. Lundsgaard-Hansen and B. Tschirren, Modified fluid gelatin as a plasma substitute, in Progress in Clinical and Biological Research, Vol 19, Blood Substitutes and Plasma Expanders (G. A. Jamieson and T. J. Greenwalt, eds.), A. R. Liss, New York, 1978, p. 227.
2. P. Labrude and C. Vigneron, Les substituts du sang: revue générale et perspectives, Lyon Pharma., 26, 629 (1975).
3. L. Thorén, Dextran as a plasma volume substitute, in Progress in Clinical and Biological Research Vol. 19, Blood Substitutes and Plasma Expanders (G. A. Jamieson and T. J. Greenwalt, eds.) A. R. Liss, New York, 1978, p. 265.
4. W. L. Thompson, Hydroxyethyl starch, in Progress in Clinical and Biological Research, Vol. 19, Blood Substitutes and Plasma Expanders (G. A. Jamieson and T. J. Greenwalt, eds.), A. R. Liss, New York, 1978, p. 283.
5. B. A. Alexander, Effects of plasma expanders on coagulation and hemostasis: dextran, hydroxyethyl starch, and other macromolecules revisited, in Progress in Clinical and Biological Research, Vol. 19, Blood Substitutes and Plasma Expanders (G. A. Jamieson and T. J. Greenwalt, eds.), A. R. Liss, New York, 1978, p. 293.
6. A. L. Gropper, L. G. Raisz, andW. H. Amspacher, Plasma expanders, Int. Abstr. Surg., 95, 521 (1952).
7. Rheomacrodex, EGIC, Arts Graphiques de Paris, 1975.
8. M. Yalpani, Studies in Organic Chemistry, Vol. 36, Polysaccharides, Syntheses, Modifications and Structure/Property Relations, Elsevier, Amsterdam, 1988.
9. A. M. Basedow and K. H. Ebert, Production, characterization and solution properties of dextran fractions of narrow molecular weight distribution, J. Polym. Sci., 66, 101 (1979).
10. P. W. Rand, Viscosity of normal human blood under normothermic and hypothermic conditions, J.Appl. Physiol., 19, 117 (1964).
11. K. Gekko, Solution properties of dextran and its ionic derivatives, in Solution Properties of Polysaccharides, ACS Symp. Ser., 150, 415 (1981).
12. J. D. Oliver and W. M. Deen, Random-coil model for glomerular sieving of dextran, Bull. Math. Biol., 56, 369 (1994).
13. G. Arturson and G. Wallenius, Renal clearance of dextran of different molecular sizes in normal humans, Scand. J. Clin. Lab. Invest., 16, 81 (1964).
14. R. Terry, C. L. Yuile, A. Golodetz, C. E. Philips, and R. R. White, Metabolism of dextran-plasma volume expander: radioactive C-labeled dextran, J. Lab. Clin. Med., 42, 6 (1953).
15. U. F. Gruber, Pharmacokinetics of dextran, Anesth. Anal. Rean., 33, 505 (1976).
16. E. Vicaut, X. Hou, L. Decuypere, A. Taccoen, and M. Duvelleroy, Red blood cell aggregation and microcirculation in rat cremaster muscle, Int. J. Microcirc, 14, 14 (1994).
17. A. Jeanes, Immunochemical and related interactions with dextrans reviewed in terms of improved structural information, Mol. Immunol, 23, 999 (1986).
18. J. Ring and K. Messmer, Infusion therapy with colloidal volume substitute, Lancet, 1, 466 (1977).
19. A. T. Cox, H. S. Ho, and R. A. Gunther, High level of arginine vasopressin and 7.5% NaCl/6% Dextran 70 solution: cardiovascular and renal effects, Shock, 1, 372 (1994).
20. C. Bodiou, F. Bavoux, and B. Vandel, Dextrans et accouchement: souffrance fcetale majeure, Rech. Gynecol, 1, 7 (1989).
21. N. W. Thomson, Hydroxyethyl starch: experimental and clinical use, in Acute Fluid Replacement in the Therapy Shock (T. I. Malinin, R. Zeppa, W. R. Drucker and A. Callahan, eds.) Stratton Intercontinental Medical, 1974, p. 211.
22. K. B. Moser, Hydroxyethylated starches, in Modified Starches: Properties and Uses (O. B. Wurburg, ed.) CRC Press, Boca Raton, Fla., 1986, p. 79.
23. U. Klotz and H. Kroemer, Clinical pharmacokinetiks considerations in the use of plasma expanders, Clin. Pharmacokin., 12, 123 (1987).
24. W. L. Thompson, T. Fukushima, R. B. Rutherford, and R. P. Walton, Intravascular persistence, tissue accumulation and excretion of hydroxyethyl starch, Infusionther. Klin. Ernaehr. Forsch. Prax., 6 151 (1979).
25. S. P. Farrow, M. Hall, and C. R. Ricketts, Changes in the molecular composition of circulating hydroxyethyl starch, Br. J. Pharmacol., 38, 725 (1970).
26. J. M. Mischler, The hydroxyethylated amylopectins: model substances comprising a two-variable system for the design of specific-acting volaemic colloids, Int. J. Clin. Pharm., 18, 67 (1980).
27. H. P. Haring, P. Pohl, W. Schimetta, W. Polz, and F. Aichner, Hydroxyethylstarch: effect of molar substitution on hemorheologic parameters: a clinical double study, Clin. Hemorheol., 14, 11 (1994).
28. W. Metcalf, A. Papadopoulos, R. Tufaro, and A. Barth, A clinical physiologic study of hydroxyethyl starch, Surg. Gynecol. Obstet., 115, 199 (1970).
29. K. Korttila, P. Grohn, A. Gordin, S. Sundberg, H. Salo, E. Nissinen, and M. A. K. Mattila, Effect of hydroxyethyl starch and dextran on plasma volume and blood hemostasis and coagulation, J. Clin. Pharmacol, 24, 273 (1984).
30. G. F. Vontempelhoff and L. Heilmann, The effect of plasma volume expansion on the utero-placental perfusion, Clin. Hemorheol, 13, 729 (1993).
31. B. Vollmar, G. Lang, M. D. Menger, and K. Messmer, Hypertonic hydroxyethylstarch restores hepatic microvascular perfusion in hemorrhagic shock, Am. J. Physiol, 266, H1927 (1994).
32. M. J. Cullen and M. Singer, Severe anaphylactoid reaction to hydroxyethylstarch, Anaesthesia, 45, 1041 (1990).
33. J. Baron, Pharmacology of low molecular weight hydroxyethylstarches, Ann. Fr. Anesth. Reanim., 11, 509 (1992).
34. P. Dewachter, M. C. Laxenaire, M. Donner, M. Kurtz, and J. F. Stoltz, In vivo rheological effects of plasma substitutes, Ann. Fr. Anesth. Reanim., 11, 516 (1992).
35. N. Rosencher, N. Vassilieff, V. Guigonis, P. Toulon, and C. Conseiller, Effects of Elohes® on haemosta-sis in orthopedic surgery, Ann. Fr. Anesth. Reanim., 11, 526 (1992).
36. M. Besnard, G. Fauchon, C. Thomassin, J. L. Gerard, B. Locker, and H. Bricard, Efficiency and tolerance to Elohes® 6% for intraoperative normovolaemic haemodilution, Ann. Fr. Anesth. Reanim., IT. 531 (1992).
37. B. Guidet, F. Staikowsky, T. Vassal, G. Offenstadt, and P. Amstutz, Comparing 6% hydroxyethyl starch with albumin during plasma exchange, Ann. Fr. Anesth. Reanim., 11, 534 (1992).
38. B. Lartigue, J. Barre, P. Nguyen, and G. Potron, Comparative study of hydroxyethylstarch 200/0.62 versus dextran 60 in hemodilution during total hip replacement: influence on hemorheological parameters, Clin. Hemorheol, 13, 779 (1993).
39. L. Mastroianni, H. B. C. Low, J. Rollman, M. Wagle, B. Bleske, and M. S. S. Chow, A comparison of 10% Pentastarch and 5% albumin in patients undergoing open-heart surgery, J. Clin. Pharmacol, 34, 34 (1994).
40. Progress in Clinical and Biological Research, Vol. 19, Blood Substitutes and Plasma Expanders (G. A. Jamieson and T. J. Greenwalt, eds.) A. R. Liss, New York, 1978.
41. Progress in Clinical and Biological Research, Vol. 122, Research in Blood Substitute Research (R. B. Bolin, R. P. Geyer, and G. J. Nemo, ed.) A. R. Liss, New York, 1982.
42. Abstracts from the 3rd International Symposium on Blood Substitutes, Biomat. Art. Cells Art. Org., 15, 343(1987).
43. E. Dellacherie, P. Labrude, C. Vigneron, and J. G. Riess, Synthetic carriers of oxygen, in Critical Reviews in Therapeutic Drug Carrier Systems, (S. D. Bruck, ed.) Vol. 3, CRC Press, 1987, p.
44. R. Winslow and T. M. S. Chang, eds. Abstracts of the International Symposium on Red Cell Substitutes, ISSN 0-890553-3, San Francisco, 1989.
45. T. M. S. Chang, ed., Blood Substitutes and Oxygen Carriers, Marcel Dekker, New York, 1993.
46. Proceedings of the 6th International Symposium on Blood Substitutes, Art. Cells Blood Subs. Immob. Biotech., 22, (1994).
47. M. F. Perutz, The hemoglobin molecule: The Crosnian Lecture, Proc. R. Soc. London Ser. B., 173, 113 (1969).
48. E. Antonini and M. Brunori, Frontiers of Biology, Vol. 21, Hemoglobin and Myoglobin in their Reactions with Ligands, North Holland, Amsterdam, 1971, p. 135.
49. E. Antonini, L. Rossi-Bernardi, and E. Chiancone, in Methods in Enzymology, Vol. 76, Hemoglobins (S. P. Colowick and N. O. Kaplan eds.) Academic Press, New York, 1981, p. 417.
50. K. Imai, Allosteric Effects in Haemoglobin, Cambridge University Press, Cambridge, 1982.
51. S. F. Rabiner, J. R. Helbert, H. Lopas, and L. H. Friedman, Evaluation of a stroma-free hemoglobin solution for use as plasma expander, J. Exp. Med., 126, (1967).
52. S-C. Tarn, J. Blumenstein, and J. T-F. Wong, Soluble dextran-hemoglobin complex as a potential blood substitute, Proc. Natl. Acad. USA, 73, 2128 (1976).
53. J. E. Chang and J. T-F. Wong, Synthesis of soluble dextran-hemoglobin complexes of different molecular sizes, Can. J. Biochem., 55, 398 (1977).
54. P. G. Cunnington, N. S. Jenkins, S. C. Tarn, and J-T. F. Wong, Oxygen-binding and immunological properties of complexes between dextran and animal hemoglobin, Biochem. J., 193, 261 (1981).
55. J. E. Baldwin, B. Gill, J. P. Whitten, and H. Taegtmeyer, Synthesis of polymer-bound hemoglobin samples, Tetrahedron, 37, 1723 (1981).
56. J. Blumenstein, S. C. Tarn, J. E. Chang, J-T. F. Wong, Experimental transfusion of dextran-hemoglobin, in Progress in Clinical and Biological Research, Vol. 19, Blood Substitutes and Plasma Expanders (G. A. Jamieson and T. J. Greenwalt, eds.) A. R. Liss, New York, 1978, p. 205.
57. J. Sempik, R. G. Humphries, J. Mann, and J. Wilson, Blood replacement by dextran-hemoglobin complex and dextran in chloralose anesthetized cats, in Oxygen-Carrying Colloidal Blood Substitutes (R. Frey, H. Beibarth, and K. Stossek, eds.) Zuckschwerdt Verlag, Munich, 1982, p. 121.
58. F. Bonneaux, P. Labrude, and E. Dellacherie, Preparation and oxygen-binding properties of soluble covalent hemoglobin-dextran conjugates, Experientia, 37, 884 (1981).
59. E. Dellacherie, F. Bonneaux, P. Labrude, and C. Vigneron, Modification of human hemoglobin by covalent association with soluble dextran, Biochim. Biophys. Acta, 749, 106 (1983).
60. P. G. Pietta, M. Pace, G. Palazzini, and A. Agostini, Comparison of the properties of human hemoglobin covalently bound to carboxyldextrans with free and polymerized hemoglobin, Prep. Biochem., 14, 313 (1984).
61. M. Beez and W. Rothe, Colloidal volume substitute composition from hydroxyethyl starch and hemoglobin, Ger. Offen 2,616,086 (1977).
62. L. C. Cerny, D. M. Stasiw, E. L. Cerny, J. E. Baldwin, and B. Gill, A hydroxyethyl starch-hemoglobin polymer as a blood substitute, Clin. Hemorheol, 2, 355 (1982).
63. L. C. Cerny, E. L. Cerny, and M. E. Cerny, J. E. Baldwin, and B. Gill, Mixtures of whole blood and hydroxyethyl starch hemoglobin polymers, Crit. Care Med., 11, 739 (1983).
64. K. Ajisaka, and Y. Iwashita, Modified hemoglobin suitable for use as oxygen carriers for blood substitutes, Eur. Patent 0,043,675 (1982).
65. R. E. Benesch, R. Benesch, R. D. Renthal, and N. Maeda, Affinity labeling of the polyphosphate binding site of hemoglobin, Biochemistry, 11, 3576 (1972).
66. A. S. Acharya, A. Di Donato, and J. M. Manning, Binding of glyoxalate to hemoglobin and subsequent reductive carboxymethylation, Fed. Proc, 41, 1174 (1982).
67. A. G. Greenburg and P. W. Maffuid, Modification of hemoglobin: ring opened dials, in Progress in Clinical and Biological Research, Vol. 122, Research in Blood Substitute Research (R. B. Bolin, R. P. Geyer, and G. J. Nemo, eds.) A. R. Liss, New York, 1982, p. 9.
68. B. Hedlund, J. Carlsson, R. Condie, and C. Drayton, Aspects of large scale production of a hemoglobin based blood substitute, in Progress in Clinical and Biological Research, Vol. 122, Research in Blood Substitute Research (R. B. Bolin, R. P. Geyer, andG. J. Nemo, eds.) A. R. Liss, New York, 1982, p. 71.
69. J. T. Wong, Rightshifted dextran-hemoglobin as blood substitute, Biomat. Art. Cells, Art. Organs, 16, 237 (1988).
70. L. C. Cerny, E. L. Cerny, C. L. Cerny, M. Reath, M. Liszczynskyj, and S. Gabel, Some potential blood substitutes, Clin. Hemorheol., 8, 621 (1988).
71. K. Iwasaki, K. Ajisaka, and Y. Iwashita, Hemoglobin-inulin conjugate as an oxygen carrying blood substitute, Biochem. Biophys. Res. Com., 113, 513 (1983).
72. R. Kluger, J. Wodzinska, R. T. Jones, C. Head, T. S. Fujita, and D. Shih, Three-point cross-linking: potential red cell substitutes from the reaction of trimesoyl tris(methyl phosphate) with hemoglobin, Biochemistry, 31,1551 (1992).
73. S. R. Snyder, E. V. Welty, R. Y. Walder, L. A. Williams, and J. A. Walder, HbXL99a: a hemoglobin derivative that is cross-linked between the a subunits is useful as a blood substitute, Proc. Natl. Acad. Sci. USA, 84, 7280(1987).
74. D. Looker, D. Abbot-Brown, R Cozart, S. Durfee, S. Hoffman, A. J. Mathews, J. Miller-Roehrich, S. Shoemaker, S. Trimble, G. Fermi, N. H. Komiyama, K. Nagai, and G. L. Stetler, A human recombinant haemoglobin designed for use as a blood substitute, Nature, 356, 258 (1992).
75. D. Klett, M. Grandgeorge, and E. Dellacherie, Fixation of aldehydic dextrans onto human hemoglobin, Biopolymers, 32,517 (1992).
76. K. Ruckpaul, H. Rein, G-R, Janig, W. Pfeil, O. Ristau, G. Damaschun, H. Damaschun, J. J. Miiller, H-V. Purschel, J. Behlke, and W. Scheler, Interaction of hemoglobin with ions: effect of heparin on the oxygen affinity of adult human hemoglobin, Stud. Biophys., 34, 81 (1972).
77. G. Amiconi, L. Zolla, P. Vecchini, M. Brunori, and E. Antonini, The effect of macromolecular polyanions on the functional properties of human hemoglobin, Eur. J. Biochem., 76, 336 (1977).
78. D. Sacco and E. Dellacherie, Interaction of a macromolecular polyanion, dextran sulfate, with human hemoglobin, FEBS Lett, 199, 254 (1986).
79. D. Sacco, F. Bonneaux, and E. Dellacherie, Interaction of haemoglobin with dextran sulphates and the oxygen-binding properties of the covalent conjugates, Int. J. Biol. Macromol., 10, 305 (1988).
80. T. Q. Nguyen, Interactions of human hemoglobin with high-molecular-weight dextran sulfate and di-ethylaminoethyl dextran, Makromol. Chem., 187, 2567 (1986).
81. W. N. Poillon and B. C. Kim, Effects of macromolecular polyanions on the solubility of deoxyhemoglobin S, Hemoglobin, 12, 369 (1988).
82. W. Feller, N. Macht, and J. G. Böttrich, Blood substitute, U.S. Patent 4,920,194 (1990).
83. D. Sacco, D. Klett-Zygmunt, and E. Dellacherie, A re-investigation of the phosphorylation of dextran with polyphosphoric acid: evidence for the formation of different types of phosphate moieties, Carbohydr. Res., 184, 193 (1988).
84. D. Zygmunt, P. Labrude, C. Vigneron, D. Sacco, and E. Dellacherie, Étude des interactions entre des phosphates de dextrane et l’hmoglobine humaine, J. Chim. Phys., 85, 315 (1988).
85. D. Sacco, D. Klett-Zygmunt, C. Vigneron and E. Dellacherie, Covalent fixation of hemoglobin to dextran phosphates decreases its oxygen affinity, Biochim. Biophys. Acta, 1041, 279 (1990).
86. F. Prouchayret, F. Bonneaux, M. Léonard, D. Sacco, and E. Dellacherie, Soluble functional polymers for human haemoglobin modification for blood substitution, Brit. Polym. J., 23, 251 (1990).
87. E. Dellacherie, Polymer-linked hemoglobin as a potential blood substitute, Clin. Materials, 6,199 (1990).
88. E. Dellacherie and C. Vigneron, Hemoglobin-based artificial blood: new polymeric derivatives of hemoglobin with low oxygen affinity, Int. J. Artif. Organs, 14, 28 (1991).
89. F. Prouchayret, D. Sacco, and E. Dellacherie, On the use of watersoluble carbodiimides for binding carboxylic compounds to aminated dextrans, Polym. Bull., 21, 309 (1989).
90. D. Sacco, F. Prouchayret and E. Dellacherie, Synthesis and characterization of dextran carboxy-lates for the specific chemical modification of human hemoglobin, Makromol. Chem., 190, 1671 (1989).
91. E. Dellacherie, M. Grandgeorge, F. Prouchayret, and G. Fasan, Hemoglobin linked to polyanionic polymers as potential red blood cell substitutes, Biomat. Art. Cells Immob. Biotech., 20, 309 (1992).
92. D. Sacco, F. Prouchayret, and E. Dellacherie, Effect of benzene polycarboxylates on the functional properties of human hemoglobin, Biomat. Art. Cells Immob. Biotech., 20, 331 (1992).
93. F. Prouchayret and E. Dellacherie, Low oxygen affinity derivatives of human hemoglobin by fixation of polycarboxylic dextran to the oxyform, Biopolymers, 33, 1803 (1993).
94. F. Prouchayret, G. Fasan, M. Grandgeorge, C. Vigneron, P. Menu, and E. Dellacherie, A potential blood substitute from carboxylic dextran and oxyhemoglobin. I. Preparation, purification and characterization, Biomat. Art. Cells Immob. Biotech., 20, 319 (1992).
95. P. Quellec, M. Leonard, M. Grandgeorge, and E. Dellacherie, Human hemoglobin conjugated to car-boxylate dextran as a potential red blood cell substitute. I. Further physico-chemical characterization, Art. Cells Blood Subs. Immob. Biotech., 22, 669 (1994).
96. B. Faivre, P. Menu, P. Labrude, M. Grandgeorge, C. Vigneron, and E. Dellacherie, A potential blood substitute from carboxylic dextran and oxyhemoglobin. II. Physicochemical and physiological assessments: preliminary results on Guinea pig, Biomat. Art. Cells Immob. Biotech., 20, 319 (1992).
97. P. Menu, B. Faivre, P. Labrude, P. Riffard, M. Grandgeorge and C. Vigneron, Human hemoglobin conjugated to carboxylate dextran as a potential red blood cell substitute. II. Toxicological and pharmacological evaluation, Art. Cells Blood Subs. Immob. Biotech., 22, 551 (1994).
98. B. Faivre, P. Menu, P. Labrude, M. Grandgeorge, and C. Vigneron. Methemoglobin formation after dextran-benzene tetracarboxylate hemoglobin administration in guinea pigs. Attempts to dioxidation of hemoglobin, Art. Cells Blood Subs. Immob. Biotech., 22, 543 (1994).
99. B. Faivre, Un transporteur d’oxygène à visée transfusionelle: l’hémoglobine-dextrane-benzène tétracarboxylate: Evaluation pré-clinique chez le cobaye, Ph. D. Thesis, Nancy, France (1993).
100. M. L. Huguet, F. Prouchayret, M. Grandgeorge, and E. Dellacherie, Comparison of the properties of dextran and hydroxyethyl starch substituted with benzene tetracarboxylate in terms of their use in blood transfusion, Carbohydr. Polym., 20, 125 (1993).
101. E. Maout, M. Grandgeorge, and E. Dellacherie, Hydroxyethyl starch conjugated to human hemoglobin for use in blood transfusion: comparison with dextran conjugates, in Frontiers in Biomedicine and Biotechnology, Vol. 1, Carbohydrates and Carbohydrate Polymers, Analysis, Biotechnology, Modification, Biomedical and Other Applications (M. Yalpani, ed.) ATL Press, Mount Prospect, 1993, p. 132.
102. J. C. Hsia, Pasteurizable, freeze-driable hemoglobin-based blood substitute, U.S. Patent 4,857,636 (1989).
103. L. Moore, R. M. Fishman, M. E. Ledford, and A. Zegna, Molecular weight determination of o-raffinose-polymerized human hemoglobin, Biomat. Art. Cells Immob. Biotech., 20, 293 (1992).
104. L. T. Wong, S. S. Er, D. Wicks, J. Rydall, and D. H. Pliura, Kinetics of cross-linking and oligomer-ization of human hemoglobin by periodate oxidized, ring-opened saccharides, Proceedings of the 5th International Symposium on Blood Substitutes, New Frontiers, San Diego, 1993, H77.
105. R. T. Jones, C. Head, L. T. Wong, S. S. Er, D. Wicks, and D. H. Pliura, Characterization of o-raffinose crosslinked hemoglobin tetramer, Proceedings of the 5th International Symposium on Blood Substitutes, New Frontiers, San Diego, 1993, H76.
106. I. A. Sherman, J. A. Dlugosz, V. Perelman, C. J. C. Hsia, and L. T. Wong, Systemic hemodynamic and microvascular responses to a 33% blood volume exchange with whole blood, stroma-free hemoglobin, and o-raffinose polymerized-hemoglobin solutions, Proceedings of the 5th International Symposium on Blood Substitutes, New Frontiers, San Diego, 1993, H100.